Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody
© 2023. The Author(s)..
Rodent-borne hantaviruses are prevalent worldwide and upon spillover to human populations, cause severe disease for which no specific treatment is available. A potent antibody response is key for recovery from hantavirus infection. Here we study a highly neutralizing human monoclonal antibody, termed SNV-42, which was derived from a memory B cell isolated from an individual with previous Sin Nombre virus (SNV) infection. Crystallographic analysis demonstrates that SNV-42 targets the Gn subcomponent of the tetrameric (Gn-Gc)4 glycoprotein assembly that is relevant for viral entry. Integration of our 1.8 Å structure with the (Gn-Gc)4 ultrastructure arrangement indicates that SNV-42 targets the membrane-distal region of the virus envelope. Comparison of the SNV-42 paratope encoding variable genes with inferred germline gene segments reveals high sequence conservation, suggesting that germline-encoded antibodies inhibit SNV. Furthermore, mechanistic assays reveal that SNV-42 interferes with both receptor recognition and fusion during host-cell entry. This work provides a molecular-level blueprint for understanding the human neutralizing antibody response to hantavirus infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Nature microbiology - 8(2023), 7 vom: 15. Juli, Seite 1293-1303 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stass, Robert [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Monoclonal |
---|
Anmerkungen: |
Date Completed 07.07.2023 Date Revised 19.07.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41564-023-01413-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358237017 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358237017 | ||
003 | DE-627 | ||
005 | 20231226074321.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41564-023-01413-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1194.xml |
035 | |a (DE-627)NLM358237017 | ||
035 | |a (NLM)37322112 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stass, Robert |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.07.2023 | ||
500 | |a Date Revised 19.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a Rodent-borne hantaviruses are prevalent worldwide and upon spillover to human populations, cause severe disease for which no specific treatment is available. A potent antibody response is key for recovery from hantavirus infection. Here we study a highly neutralizing human monoclonal antibody, termed SNV-42, which was derived from a memory B cell isolated from an individual with previous Sin Nombre virus (SNV) infection. Crystallographic analysis demonstrates that SNV-42 targets the Gn subcomponent of the tetrameric (Gn-Gc)4 glycoprotein assembly that is relevant for viral entry. Integration of our 1.8 Å structure with the (Gn-Gc)4 ultrastructure arrangement indicates that SNV-42 targets the membrane-distal region of the virus envelope. Comparison of the SNV-42 paratope encoding variable genes with inferred germline gene segments reveals high sequence conservation, suggesting that germline-encoded antibodies inhibit SNV. Furthermore, mechanistic assays reveal that SNV-42 interferes with both receptor recognition and fusion during host-cell entry. This work provides a molecular-level blueprint for understanding the human neutralizing antibody response to hantavirus infection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
650 | 7 | |a Glycoproteins |2 NLM | |
700 | 1 | |a Engdahl, Taylor B |e verfasserin |4 aut | |
700 | 1 | |a Chapman, Nathaniel S |e verfasserin |4 aut | |
700 | 1 | |a Wolters, Rachael M |e verfasserin |4 aut | |
700 | 1 | |a Handal, Laura S |e verfasserin |4 aut | |
700 | 1 | |a Diaz, Summer M |e verfasserin |4 aut | |
700 | 1 | |a Crowe, James E |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Bowden, Thomas A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature microbiology |d 2016 |g 8(2023), 7 vom: 15. Juli, Seite 1293-1303 |w (DE-627)NLM257483241 |x 2058-5276 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2023 |g number:7 |g day:15 |g month:07 |g pages:1293-1303 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41564-023-01413-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2023 |e 7 |b 15 |c 07 |h 1293-1303 |